Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Advances in Pharmacology (San Diego, Calif.)
|
July 4, 2020
Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence
Lynnette A Averill, Samar Fouda, James W Murrough, et al.
BMC Neurology
|
April 6, 2017
Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials
Abdelrahman Ibrahim Abushouk, Ahmed Elmaraezy, Amro Aglan, et al.
NPP - Digital Psychiatry and Neuroscience
|
June 26, 2024
Findings of PTSD-specific deficits in default mode network strength following a mild experimental stressor
Christopher L Averill, Lynnette A Averill, Teddy J Akiki, et al.
Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit
|
May 12, 2018
Tobacco smoking in Egypt: a scoping literature review of its epidemiology and control measures
Samar Fouda, Mohamed Kelany, Nada Moustafa, et al.
CNS & Neurological Disorders Drug Targets
|
November 11, 2015
Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis
Ahmed Negida, Ahmed Menshawy, Gehad El Ashal, et al.
Chronic Stress (Thousand Oaks, Calif.)
|
January 18, 2021
Pretreatment Brain Connectome Fingerprint Predicts Treatment Response in Major Depressive Disorder
Siyan Fan, Samaneh Nemati, Teddy J Akiki, et al.
Journal of Affective Disorders
|
May 29, 2025
Functional connectome-based predictive modeling of suicidal ideation
Lynnette A Averill, Amanda J F Tamman, Samar Fouda, et al.
Iscience
|
January 10, 2020
A Unique Brain Connectome Fingerprint Predates and Predicts Response to Antidepressants
Samaneh Nemati, Teddy J Akiki, Jeremy Roscoe, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 23, 2020
A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressants
Chadi G Abdallah, Kyung-Heup Ahn, Lynnette A Averill, et al.
Journal of Affective Disorders
|
February 1, 2022
mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression
Lynnette A Averill, Christopher L Averill, Ralitza Gueorguieva, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Advances in Pharmacology (San Diego, Calif.)
|
July 4, 2020
Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence
Lynnette A Averill, Samar Fouda, James W Murrough, et al.
BMC Neurology
|
April 6, 2017
Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials
Abdelrahman Ibrahim Abushouk, Ahmed Elmaraezy, Amro Aglan, et al.
NPP - Digital Psychiatry and Neuroscience
|
June 26, 2024
Findings of PTSD-specific deficits in default mode network strength following a mild experimental stressor
Christopher L Averill, Lynnette A Averill, Teddy J Akiki, et al.
Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit
|
May 12, 2018
Tobacco smoking in Egypt: a scoping literature review of its epidemiology and control measures
Samar Fouda, Mohamed Kelany, Nada Moustafa, et al.
CNS & Neurological Disorders Drug Targets
|
November 11, 2015
Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis
Ahmed Negida, Ahmed Menshawy, Gehad El Ashal, et al.
Chronic Stress (Thousand Oaks, Calif.)
|
January 18, 2021
Pretreatment Brain Connectome Fingerprint Predicts Treatment Response in Major Depressive Disorder
Siyan Fan, Samaneh Nemati, Teddy J Akiki, et al.
Journal of Affective Disorders
|
May 29, 2025
Functional connectome-based predictive modeling of suicidal ideation
Lynnette A Averill, Amanda J F Tamman, Samar Fouda, et al.
Iscience
|
January 10, 2020
A Unique Brain Connectome Fingerprint Predates and Predicts Response to Antidepressants
Samaneh Nemati, Teddy J Akiki, Jeremy Roscoe, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 23, 2020
A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressants
Chadi G Abdallah, Kyung-Heup Ahn, Lynnette A Averill, et al.
Journal of Affective Disorders
|
February 1, 2022
mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression
Lynnette A Averill, Christopher L Averill, Ralitza Gueorguieva, et al.
Page
of 2